CapsoVision, Inc (CV) - Dilution Analysis

10-Q filing | 47.5M shares outstanding

S-1 filing: The Selling Stockholders identified in this prospectus are offering on a resale basis an aggregate of 2,867,089 shares of common stock issued to the Selling Stockholders pursuant to the Securities Purchase Agreement.

10-K filing | 49.8M shares outstanding

10-Q filing | 46.2M shares outstanding

10-Q filing | 46.8M shares outstanding

S-1/A filing: This is an S-1/A filing for an initial public offering of common stock. The company is offering 5,250,000 shares of common stock with an expected price range of $5.00 to $5.50 per share. The underwriters have an option to purchase up to an additional 787,500 shares to cover over-allotments. The company intends to list its common stock on Nasdaq under the symbol CV.

S-1/A filing: The company is filing an S-1/A form to offer 5,250,000 shares of common stock with an anticipated initial public offering price between $5.00 and $5.50 per share.

S-1/A filing: This is an S-1/A filing for an initial public offering of common stock. The company plans to offer 5,250,000 shares with an anticipated price between $5.00 and $5.50 per share. Underwriters have an over-allotment option to purchase up to 787,500 additional shares. The company has applied to list its shares on Nasdaq under the symbol 'CV'.

S-1 filing: The Benchmark Company is offering common stock in an initial public offering, with an anticipated price between $ and $ per share. Underwriters have an over-allotment option for additional shares. The company intends to list its common stock on Nasdaq under the symbol 'CV'.